UK markets close in 7 hours 22 minutes
  • FTSE 100

    7,092.60
    +18.54 (+0.26%)
     
  • FTSE 250

    22,687.21
    +27.79 (+0.12%)
     
  • AIM

    1,232.92
    +1.83 (+0.15%)
     
  • GBP/EUR

    1.1703
    +0.0001 (+0.01%)
     
  • GBP/USD

    1.3968
    +0.0004 (+0.03%)
     
  • BTC-GBP

    23,570.60
    -915.16 (-3.74%)
     
  • CMC Crypto 200

    795.28
    -14.92 (-1.84%)
     
  • S&P 500

    4,241.84
    -4.60 (-0.11%)
     
  • DOW

    33,874.24
    -71.34 (-0.21%)
     
  • CRUDE OIL

    73.46
    +0.38 (+0.52%)
     
  • GOLD FUTURES

    1,776.80
    -6.60 (-0.37%)
     
  • NIKKEI 225

    28,875.23
    +0.34 (+0.00%)
     
  • HANG SENG

    28,851.26
    +34.19 (+0.12%)
     
  • DAX

    15,508.39
    +52.00 (+0.34%)
     
  • CAC 40

    6,586.56
    +35.49 (+0.54%)
     

Vistin Pharma ASA: Mandatory notification of trade

Hilde Merete Hagen, VP Quality & regulatory Affairs in Vistin Pharma ASA, and a primary insider, has on 18th of May 2021 sold 14 182 shares in Vistin Pharma ASA at an average price of NOK 24.0 per share.

Following this transaction Hilde Merete Hagen do not hold any shares in Vistin Pharma ASA.


Attachment


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting